PainScience.com Sensible advice for aches, pains & injuries
 
 

microblog

Doubting doubts

Paul Ingraham ARCHIVEDMicroblog posts are archived and rarely updated. In contrast, most long-form articles on PainScience.com are updated regularly over the years.

Many people have complained that my article about the sketchiness of trigger point science undermines the integrity and value of my book about trigger points. I’ve had people tell me they refuse to buy my book because “apparently you can’t make up your mind” or because they feel “betrayed” by my doubts. One reader pointed out that the only negative “review” he could find of my book was written by … me!

There’s no doubt it’s unusual, but I think questioning key points in my own book increases its value and integrity. Regardless, it’s clear that many people are disoriented by my “doubts” article, so I’ve (reluctantly) added this disclaimer to the introduction:

We know something is going on, and it is often labelled “trigger point” pain, wisely or unwisely. No one doubts that: not me, not the harshest skeptics, not anyone. What is in doubt is the explanation, the nature of the beast. Although this might seem to contradict the purpose of my book, it does not: armchair speculation about the biology of trigger points should not discourage anyone from rational exploration of their treatment options. The purpose of this article is to address the reasonable and fair questions of skeptics about the science of trigger points. In any case, I do not conclude or condemn anything at this time — I just question and consider. I hope readers will respect the fact that I’m willing to ask the tough questions, even if they aren’t superficially good for my bottom line.

P.S. I updated this article substantially in January. If you haven’t looked at it recently, it’s changed. There’s also a freshly updated audio version of it.

This is the MICROBLOG: small posts about interesting stuff that comes up while I’m updating & upgrading dozens of featured articles on PainScience.com. Follow along on Twitter, Facebook, or RSS. Sorry, no email subscription option at this time, but it’s in the works.